EUVIMEDEUVIMED entdecken
Crossref

Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C Among US Adults

Eric W Hall iD, Amy L Sandul iD, Saleem Kamili, Emily J Cartwright iD, Hasan Symum, Carolyn Wester

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Eric W Hall und 5 weiteren Autor:innen. Beteiligte Einrichtung: OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Hepatitis C. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: US Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, National Center for HIV, Viral Hepatitis, STD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diagnosis of infection with hepatitis C virus (HCV) is the first step to accessing curative treatment, yet many infected adults in the United States are unaware of their infection. Viral-first HCV testing strategies may improve diagnosis. We assessed the cost-effectiveness of several hepatitis C testing strategies compared with the currently recommended testing algorithm.

Methods

We used a decision tree framework with a Markov model of hepatitis C disease progression, to model a cohort representative of US adults at average risk. We modeled 4 strategies: anti-HCV test with automatic nucleic acid test (NAT) for HCV RNA when the anti-HCV result is reactive (comparator); anti-HCV test with automatic hepatitis C core antigen (HCVcAg) test when the anti-HCV result is reactive, followed by NAT for HCV RNA when the HCVcAg result is not reactive (intervention 1); concurrent anti-HCV and HCVcAg tests with automatic NAT for HCV RNA for discordant anti-HCV and HCVcAg results (intervention 2); and NAT for HCV RNA (intervention 3). We compared costs (in 2023 US dollars), quality-adjusted life-years (QALYs) and epidemiologic outcomes for the lifetime of the cohort.

Results

Relative to the comparator, intervention 1 resulted in the same number of HCV diagnoses and subsequent health outcomes, with cost savings of $0.26 per person.

Interventions

2 and 3 had increased costs per person ($8.60 2 and $21.48, respectively) and resulted in an increase in diagnosed infections, treated infections, and QALYs.

Conclusions

Compared with the current HCV testing approach, viral-first HCV testing approaches are potentially cost-effective strategies that resulted in gains in diagnoses and health outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CHumansCost-Benefit AnalysisUnited StatesAdultRNA, ViralHepacivirusMiddle AgedMaleMarkov ChainsDecision TreesFemaleHepatitis C AntibodiesCost-Effectiveness Analysis

Stichwörter der Autor:innen

United Statescost-effectiveness analysisdiagnosisepidemiologyhepatitis C

Substanzen

RNA, ViralHepatitis C Antibodies

Autor:innen und Institutionen

  • OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, Oregon, USA.
  • Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Infectious Diseases Section, Atlanta VA Health Care System, Decatur, Georgia, USA.

ORCID-Profile: Eric W Hall, Amy L Sandul, Emily J Cartwright

Förderung

  • US Centers for Disease Control and Prevention
  • National Center for HIV, Viral Hepatitis, STD, and TB Prevention
  • National Center for HIV, Viral Hepatitis, STD
  • TB Prevention Epidemiologic and Economic Modeling Agreement

Zitieren

APA

Hall, E. W., Sandul, A. L., Kamili, S., Cartwright, E. J., Symum, H., & Wester, C. (2025). Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C Among US Adults. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf166

Vancouver

Hall EW, Sandul AL, Kamili S, Cartwright EJ, Symum H, Wester C. Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C Among US Adults. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf166

BibTeX
@article{Hall2025,
  author = {Hall, Eric W and Sandul, Amy L and Kamili, Saleem and Cartwright, Emily J and Symum, Hasan and Wester, Carolyn},
  title = {Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C Among US Adults},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf166}
}
Kostenlos starten →